Abbvie is buying Allergan in a $63 billion pharma mega-deal

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 17 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 51%

United States Headlines News

United States Latest News,United States Headlines

The biopharmaceuticals giant and drugmaker are combining to create a leader across immunology, neuroscience, eye care and other medical fields.

Abbvie has agreed to buy Allergan in a $63 billion cash-and-stock deal. Allergan shareholders will receive 0.8660 AbbVie shares and $120.30 in cash for each Allergan share that they hold, totaling $188.24 per Allergan share. The offer represents a 45% premium to the closing price of Allergan's shares on June 24, 2019.

Abbvie has agreed to buy Allergan in a $63 billion cash-and-stock deal. Allergan shareholders will receive 0.8660 AbbVie shares and $120.30 in cash for each Allergan share that they hold, totaling $188.24 per Allergan share. The offer represents a 45% premium to the closing price of Allergan's shares on June 24, 2019.

Source: Healthcare Press (healthcarepress.net)

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 729. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

AbbVie Nears Deal to Buy Allergan for More Than $60 BillionAbbVie is nearing a deal to buy Allergan for more than $60 billion, as the two big drug makers bet a combination will deliver new sources of growth they have struggled to find on their own. TrueBubbleHead just looked at $AGN. This may change the Trade of the Week Legal cartels. Growth meaning price gouging.
Source: WSJ - 🏆 98. / 63 Read more »

AbbVie Nears Deal to Buy Allergan for More Than $60 BillionAbbVie is nearing a deal to buy Allergan for more than $60 billion, as the two big drug makers bet a combination will deliver new sources of growth they have struggled to find on their own. TrueBubbleHead just looked at $AGN. This may change the Trade of the Week Legal cartels. Growth meaning price gouging.
Source: WSJ - 🏆 98. / 63 Read more »

Eldorado Resorts to buy Caesars Entertainment for about $8.5 billionEldorado Resorts Inc has agreed to buy Caesars Entertainment Corp for about $8.5...
Source: Reuters - 🏆 2. / 97 Read more »

Eldorado Resorts takes on bigger rivals with $8.5 billion Caesars buyU.S. casino operator Eldorado Resorts Inc has agreed to buy rival Caesars Entert... If you're looking for a Laravel book that can help you to build amazing web applications, this is the best book for you! Ebook: Paperback: (Amazon Prime) laravel laravel5 framework laravelphp laravel58 php ebook Donald Fagen is looking rough. Laundry money in mode FULL !!
Source: Reuters - 🏆 2. / 97 Read more »

Caesars' stock soars after Eldorado buyout deal values casino operator at about $8.6 billionShares of Caesars Entertainment Corp. soared 16% toward an 11-month high in premarket trading Monday, after the casino operator agreed to be bought out by... how the hell can the 'El Dorado' afford to buy the much bigger more successful Caesar's...doesn't make sense...
Source: MarketWatch - 🏆 3. / 97 Read more »

Circor rejects Crane's buyout deal valued at $1.7 billionCircor International Inc. said Monday it has rejected the unsolicited buyout bid from Crane Co. given that it 'substantially undervalues' the flow...
Source: MarketWatch - 🏆 3. / 97 Read more »